Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Amedisys Q3 Adj. EPS $0.98 Misses $1.08 Estimate, Sales $556.20M Miss $561.27M Estimate

Author: Benzinga Newsdesk | October 24, 2023 04:44pm
Amedisys (NASDAQ:AMED) reported quarterly earnings of $0.98 per share which missed the analyst consensus estimate of $1.08 by 9.26 percent. This is a 14.78 percent decrease over earnings of $1.15 per share from the same period last year. The company reported quarterly sales of $556.20 million which missed the analyst consensus estimate of $561.27 million by 0.90 percent. This is a 0.32 percent decrease over sales of $557.99 million the same period last year.

Posted In: AMED


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist